Beneficios de la administración prehospitalaria de plasma en pacientes con riesgo de shock hemorrágico¿Salva vidas?
ISSN: 2171-9020
Argitalpen urtea: 2018
Zenbakien izenburua: Validez del TAC coronario 5 años
Alea: 2
Zenbakia: 41
Mota: Artikulua
Beste argitalpen batzuk: MPG Journal
Laburpena
It is extremely important in injured patients to prevent the risk for coagulopathy or hemorrhagic shock during air medical transport. Early administration of plasma in addition to standard resuscitation procedures may reduce the mortality rates. However the potencial risks are still unknown.
Erreferentzia bibliografikoak
- Cardenas JC, Holcomb JB. Time to plasma transfusion: a patient centered approach and modifiable risk factor. Transfusion 2017; 57: 869-73.
- Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon’s perspective. Hematology Am Soc Hematol Educ Program 2013; 2013: 656-9.
- Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313: 471-82.
- Pati S, Potter DR, Baimukanova G, Farrel DH, Holcomb JB, Schreiber MA. Modulating the endotheliopathy of trauma: factor concentrate versus fresh frozen plasma. J Trauma Acute Care Surg 2016; 80: 576-84.